PL368837A1 - An improved process for preparing pure ondansetron hydrochloride dihydrate - Google Patents
An improved process for preparing pure ondansetron hydrochloride dihydrateInfo
- Publication number
- PL368837A1 PL368837A1 PL02368837A PL36883702A PL368837A1 PL 368837 A1 PL368837 A1 PL 368837A1 PL 02368837 A PL02368837 A PL 02368837A PL 36883702 A PL36883702 A PL 36883702A PL 368837 A1 PL368837 A1 PL 368837A1
- Authority
- PL
- Poland
- Prior art keywords
- improved process
- hydrochloride dihydrate
- ondansetron hydrochloride
- preparing pure
- pure ondansetron
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26105201P | 2001-01-11 | 2001-01-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL368837A1 true PL368837A1 (en) | 2005-04-04 |
Family
ID=22991757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02368837A PL368837A1 (en) | 2001-01-11 | 2002-01-11 | An improved process for preparing pure ondansetron hydrochloride dihydrate |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1355881A4 (en) |
| JP (1) | JP2004526692A (en) |
| KR (3) | KR20060113792A (en) |
| CN (2) | CN1496350A (en) |
| AU (1) | AU2002236753B2 (en) |
| CA (1) | CA2433720A1 (en) |
| CZ (1) | CZ20032090A3 (en) |
| DE (1) | DE02703115T1 (en) |
| ES (1) | ES2219201T1 (en) |
| HR (1) | HRP20030631A2 (en) |
| HU (1) | HUP0400767A2 (en) |
| IL (1) | IL156835A0 (en) |
| IS (1) | IS6869A (en) |
| MX (1) | MXPA03006215A (en) |
| NO (1) | NO20033147L (en) |
| PL (1) | PL368837A1 (en) |
| SK (1) | SK9892003A3 (en) |
| TR (1) | TR200401460T3 (en) |
| WO (1) | WO2002055492A2 (en) |
| YU (1) | YU56103A (en) |
| ZA (1) | ZA200305338B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7098345B2 (en) | 2002-04-29 | 2006-08-29 | TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one |
| HU225885B1 (en) * | 2002-10-17 | 2007-11-28 | Richter Gedeon Nyrt | Process for producing ondansetron hydrochlorid dihydrate of high purity |
| FI6164U1 (en) * | 2003-01-09 | 2004-03-15 | Synthon Bv | Ondansetronformer |
| GB2398071B (en) * | 2003-01-24 | 2006-06-07 | Synthon Bv | Process for making ondansetron and intermediate thereof |
| US7696356B2 (en) | 2004-08-17 | 2010-04-13 | Taro Pharmaceutical Industries Limited | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
| EP1828141A4 (en) * | 2004-10-26 | 2009-04-01 | Ipca Lab Ltd | A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| GB8630071D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
| EP1339707A2 (en) * | 2000-10-30 | 2003-09-03 | Teva Pharmaceutical Industries Ltd. | Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
-
2002
- 2002-01-11 IL IL15683502A patent/IL156835A0/en unknown
- 2002-01-11 JP JP2002556165A patent/JP2004526692A/en active Pending
- 2002-01-11 YU YU56103A patent/YU56103A/en unknown
- 2002-01-11 EP EP02703115A patent/EP1355881A4/en not_active Withdrawn
- 2002-01-11 SK SK989-2003A patent/SK9892003A3/en not_active Application Discontinuation
- 2002-01-11 AU AU2002236753A patent/AU2002236753B2/en not_active Expired - Fee Related
- 2002-01-11 CZ CZ20032090A patent/CZ20032090A3/en unknown
- 2002-01-11 KR KR1020067020069A patent/KR20060113792A/en not_active Application Discontinuation
- 2002-01-11 KR KR10-2003-7009221A patent/KR20030068583A/en active IP Right Grant
- 2002-01-11 CA CA002433720A patent/CA2433720A1/en not_active Abandoned
- 2002-01-11 PL PL02368837A patent/PL368837A1/en not_active Application Discontinuation
- 2002-01-11 KR KR1020077010146A patent/KR20070054749A/en not_active Application Discontinuation
- 2002-01-11 HU HU0400767A patent/HUP0400767A2/en unknown
- 2002-01-11 CN CNA028062019A patent/CN1496350A/en active Pending
- 2002-01-11 ZA ZA200305338A patent/ZA200305338B/en unknown
- 2002-01-11 WO PCT/US2002/000853 patent/WO2002055492A2/en active Application Filing
- 2002-01-11 MX MXPA03006215A patent/MXPA03006215A/en unknown
- 2002-01-11 TR TR2004/01460T patent/TR200401460T3/xx unknown
- 2002-01-11 DE DE02703115T patent/DE02703115T1/en active Pending
- 2002-01-11 ES ES02703115T patent/ES2219201T1/en active Pending
- 2002-01-11 CN CNA2006101667179A patent/CN101045704A/en active Pending
-
2003
- 2003-07-08 IS IS6869A patent/IS6869A/en unknown
- 2003-07-09 NO NO20033147A patent/NO20033147L/en not_active Application Discontinuation
- 2003-08-06 HR HR20030631A patent/HRP20030631A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101045704A (en) | 2007-10-03 |
| NO20033147D0 (en) | 2003-07-09 |
| WO2002055492A2 (en) | 2002-07-18 |
| CZ20032090A3 (en) | 2004-08-18 |
| EP1355881A4 (en) | 2004-03-31 |
| NO20033147L (en) | 2003-09-02 |
| MXPA03006215A (en) | 2005-02-17 |
| HRP20030631A2 (en) | 2005-06-30 |
| AU2002236753B2 (en) | 2007-06-28 |
| EP1355881A2 (en) | 2003-10-29 |
| YU56103A (en) | 2006-05-25 |
| IL156835A0 (en) | 2004-02-08 |
| IS6869A (en) | 2003-07-08 |
| KR20030068583A (en) | 2003-08-21 |
| KR20070054749A (en) | 2007-05-29 |
| CN1496350A (en) | 2004-05-12 |
| JP2004526692A (en) | 2004-09-02 |
| HUP0400767A2 (en) | 2004-07-28 |
| TR200401460T3 (en) | 2004-08-23 |
| ZA200305338B (en) | 2004-07-12 |
| CA2433720A1 (en) | 2002-07-18 |
| SK9892003A3 (en) | 2004-05-04 |
| WO2002055492A3 (en) | 2003-02-13 |
| KR20060113792A (en) | 2006-11-02 |
| ES2219201T1 (en) | 2004-12-01 |
| DE02703115T1 (en) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG23914A (en) | Process for preparing an antichnolinergic | |
| HUP0400610A3 (en) | Improved process for preparing benzimidazole-type compounds | |
| HK1078863A1 (en) | Process for preparing (s)-pantoprazole | |
| GB0110670D0 (en) | Machine for manufacturing graft-stents | |
| IL159994A0 (en) | Process for preparing 4-aminodiphenylamine | |
| SG137677A1 (en) | Improved process for preparing polyalkenylsuccinimides | |
| HUP0300160A3 (en) | Process for preparing (+)-cis-sertraline | |
| SG115596A1 (en) | Process for preparing tert-butanol | |
| HU0104405D0 (en) | Process for preparing imidachlopid | |
| HUP0301649A3 (en) | Process for preparing azacycloalkanoylaminothiazoles | |
| HUP0300114A3 (en) | Process for preparing flavonoid-derivatives | |
| HUP0201837A3 (en) | Process for preparation n-carboxy-anhydrides | |
| IL150043A0 (en) | Method for preparing bromodifluoroacetic compounds | |
| IL156835A0 (en) | An improved process for preparing pure ondansetron hydrochloride dihydrate | |
| IL143395A0 (en) | Process for preparing alkyl- or aryloxyacetaldehydes | |
| EP1451178A4 (en) | Processes for preparing beta-d-ribofuranose derivatives | |
| GB0522075D0 (en) | Process for preparing almodipline mesylate monohydrate | |
| HUP0204443A3 (en) | Process for preparing fluoroformates | |
| HUP0401401A3 (en) | Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate | |
| HUP0401914A3 (en) | Process for preparing pyridil-alkylsulfonyl pyrazole derivatives | |
| TW521697U (en) | Improved structure for mold clamping machine | |
| CZ20011502A3 (en) | Process for preparing antidiabetic | |
| HU0104169D0 (en) | Process for plain-vine-stock wine-planting | |
| SI1499623T1 (en) | PROCESS FOR PREPARING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-YL)METHYL?æ-4H-CARBAZOL-4-ONE | |
| TW524193U (en) | Mold clamping apparatus for forming mold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |